The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum
- 27 March 2003
- journal article
- review article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 17 (2), 147-153
- https://doi.org/10.1046/j.1472-8206.2003.00164.x
Abstract
Drug‐resistant malaria is primarily caused by Plasmodium falciparum, a species highly prevalent in tropical Africa, the Amazon region and South‐east Asia. It causes severe fever or anaemia that leads...Keywords
This publication has 26 references indexed in Scilit:
- Malaria in 2002Nature, 2002
- Plasmodium falciparum: pfcrtandDHFRMutations Are Associated with Failure of Chloroquine plus Proguanil Prophylaxis in TravelersThe Journal of Infectious Diseases, 2001
- Chloroquine‐Resistant MalariaThe Journal of Infectious Diseases, 2001
- Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparumMolecular and Biochemical Parasitology, 2001
- Why is it that antimalarial drug treatments do not always workPathogens and Global Health, 1998
- Estrogen Up-regulates Apolipoprotein E (ApoE) Gene Expression by Increasing ApoE mRNA in the Translating Pool via the Estrogen Receptor α-Mediated PathwayJournal of Biological Chemistry, 1997
- Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilizationMolecular Microbiology, 1997
- Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparumMolecular and Biochemical Parasitology, 1995
- REDUCED SENSITIVITY OF PLASMODIUM FALCIPARUM TO MEFLOQUINE IN WEST AFRICAThe Lancet, 1988
- REDUCED IN-VITRO SUSCEPTIBILITY TO MEFLOQUINE IN WEST AFRICAN ISOLATES OF PLASMODIUM FALCIPARUMThe Lancet, 1987